Genotyping Industry Overview 2025: Growth Projections and Market Trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Genotyping Market Covering 2025–2034?

The genotyping market size has experienced rapid growth in recent years. Its value is projected to expand from $23.04 billion in 2024 to $26.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.3%. The historical expansion of this market can be attributed to various factors such as government initiatives and funding, a rapid decline in genotyping costs, the expansion of biobanks and genetic databases, an increasing prevalence of genetic disorders, and advancements in pharmacogenomics and drug development.

The genotyping market is projected for significant expansion over the coming years. By 2029, it is forecast to reach $51.22 billion, exhibiting a compound annual growth rate (CAGR) of 17.8%. This growth during the forecast period can be attributed to factors such as increased adoption in clinical diagnostics, the growing demand for personalized medicine, a rise in research and development initiatives, and its expanding application in agriculture and livestock. Major trends anticipated for the forecast period include the rise in demand for pharmacogenomics, advancements in next-generation sequencing (ngs), the expansion in precision medicine initiatives, the growth in direct-to-consumer (dtc) genetic testing, and a focus on cancer genomics and personalized therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

Which Industry Drivers Are Expected To Accelerate The Genotyping Market From 2025 To 2029?

The growing incidence of cancer and genetic conditions is anticipated to drive the expansion of the genotyping market in the future. Cancer encompasses a wide range of diseases that can originate in almost any bodily organ or tissue, whereas genetic disorders are conditions caused, in whole or in part, by an unusual DNA sequence. Genotyping allows researchers to examine genetic variations, including single nucleotide variations, copy number variations, and significant structural alterations in DNA. This genetic testing method, known as genotyping, identifies particular gene mutations or changes that could increase an individual’s susceptibility to developing specific cancers. For example, data from the World Health Organization, a Switzerland-based international public health agency, indicated in February 2024 that around 20 million new cancer cases were recorded in 2022, leading to 9.7 million fatalities. Concurrently, an estimated 53.5 million people were living five years post-cancer diagnosis. Moreover, figures from Gene People UK, a UK-based registered charity, revealed in February 2023 that approximately 1 in every 25 children lives with a hereditary condition. This translates to 30,000 infants and children receiving new diagnoses yearly in the UK, with over 2.4 million children and adults affected by a genetic disorder. Consequently, the increasing prevalence of cancer and genetic disorders is fueling the expansion of the genotyping market.

What Are The Major Segments Identified In The Genotyping Market?

The genotypingmarket covered in this report is segmented –

1) By Product And Services: Instruments; Reagents And Kits; Bioinformatics; Genotyping Service

2) By Technology: Microarrays; Capillary Electrophoresis; Sequencing; Polymerase Chain Reaction; Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry; Other Technologies

3) By Application: Pharmacogenomics; Diagnostics And Personalized Medicine; Animal Genetics; Agricultural Biotechnology; Other Applications

4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Diagnostics And Research Laboratories; Academic Institutes; Other End-Users

Subsegments:

1) By Instruments: Sequencers; PCR Machines; Microarrays; Genotyping Platforms

2) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Next-Generation Sequencing (NGS) Kits

3) By Bioinformatics: Data Analysis Software; Genomic Data Management Tools; Cloud-based Solutions

4) By Genotyping Services: Contract Research Organizations (CRO) Services; Custom Genotyping Services; Sample Preparation Services

Which Market Trends Are Creating New Opportunities In The Genotyping Industry?

Product innovation represents a significant trend gaining traction in the genotyping market. Companies operating within this market are adopting advanced solutions to secure their competitive standing. For example, in May 2022, Neogen, a US-based food safety company, and Gencove Inc., a US-based firm specializing in sequencing platforms for genome discovery, introduced InfiniSEEK. This innovative and cost-effective solution facilitates whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis. It stands as the premier whole-genome and genotyping sequencing solution specifically designed for cattle breeders. Through InfiniSEEK, the industry now possesses a platform capable of reliably managing over 400 bovine genetic characteristics and conditions, uncovering new variables affecting desired phenotypes, and mitigating selection bias by sequencing larger portions or entire populations. The launch of this unique service offers consumers a data-rich, economical approach to profile cattle globally by integrating genome-wide sequencing data, specific genetic traits, and parentage markers.

Which Key Players Are Driving Competition In The Genotyping Market?

Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

How Is Genotyping Market Demand Varying Across Different Regions?

North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genotyping Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

Browse Through More Reports Similar to the Global Genotyping Market 2025, By The Business Research Company

Train And Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/train-and-components-global-market-report

Rail Asset Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rail-asset-management-global-market-report

Powertrain And Powertrain Parts Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/powertrain-and-powertrain-parts-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795